Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
17
YBGJ Quote, Financials, Valuation and Earnings
Last price:
$0.0104
Seasonality move
:
388.55%
Day range:
$0.0104 - $0.0104
52-week range:
$0.0079 - $0.1776
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.99x
P/B ratio:
--
Volume:
--
Avg. volume:
5.9K
1-year change:
-84.71%
Market cap:
$1.8M
Revenue:
$3.5K
EPS (TTM):
-$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
YBGJ
Yubo International Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
HOLX
Hologic, Inc.
|
$1.1B | $1.10 | 2.94% | 26.98% | $76.60 |
|
LNMG
Linike Medical Group Ltd.
|
-- | -- | -- | -- | -- |
|
NUWE
Nuwellis, Inc.
|
$2.3M | -- | 9.98% | -- | $13.00 |
|
QTRX
Quanterix Corp.
|
$38M | -$0.69 | 20.97% | -- | $7.33 |
|
VREX
Varex Imaging Corp.
|
$207.8M | $0.13 | 1.89% | 55.79% | $18.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
YBGJ
Yubo International Biotech Ltd.
|
$0.0104 | -- | $1.8M | -- | $0.00 | 0% | 12.99x |
|
HOLX
Hologic, Inc.
|
$75.36 | $76.60 | $16.8B | 31.27x | $0.00 | 0% | 4.12x |
|
LNMG
Linike Medical Group Ltd.
|
$0.0350 | -- | $121.6K | -- | $0.00 | 0% | 1.95x |
|
NUWE
Nuwellis, Inc.
|
$1.51 | $13.00 | $10.5M | -- | $0.00 | 0% | 0.41x |
|
QTRX
Quanterix Corp.
|
$6.55 | $7.33 | $306M | -- | $0.00 | 0% | 2.04x |
|
VREX
Varex Imaging Corp.
|
$13.17 | $18.00 | $552.1M | 17.58x | $0.00 | 0% | 0.68x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
YBGJ
Yubo International Biotech Ltd.
|
-9.09% | -0.726 | 5.91% | 0.05x |
|
HOLX
Hologic, Inc.
|
32.46% | 0.871 | 15.17% | 3.14x |
|
LNMG
Linike Medical Group Ltd.
|
-- | 5.621 | -- | -- |
|
NUWE
Nuwellis, Inc.
|
8.91% | -1.025 | 1.64% | 1.20x |
|
QTRX
Quanterix Corp.
|
11.31% | 1.559 | 15.83% | 2.19x |
|
VREX
Varex Imaging Corp.
|
45.7% | 1.753 | 79.9% | 1.69x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
YBGJ
Yubo International Biotech Ltd.
|
-$43.6K | -$310.1K | -- | -- | -11737.99% | -$359.1K |
|
HOLX
Hologic, Inc.
|
$584.1M | $240.9M | 7.3% | 11.09% | 22.99% | $194.8M |
|
LNMG
Linike Medical Group Ltd.
|
-- | -- | -- | -- | -- | -- |
|
NUWE
Nuwellis, Inc.
|
$1.4M | -$2.7M | -773.58% | -1004.06% | -121.65% | -$3.2M |
|
QTRX
Quanterix Corp.
|
$17.2M | -$30.2M | -26.87% | -30.04% | -74.94% | -$41.9M |
|
VREX
Varex Imaging Corp.
|
$69.8M | $15.4M | -6.79% | -13.14% | 7.35% | -$26.8M |
Yubo International Biotech Ltd. vs. Competitors
-
Which has Higher Returns YBGJ or HOLX?
Hologic, Inc. has a net margin of -11740.4% compared to Yubo International Biotech Ltd.'s net margin of 17.09%. Yubo International Biotech Ltd.'s return on equity of -- beat Hologic, Inc.'s return on equity of 11.09%.
Company Gross Margin Earnings Per Share Invested Capital YBGJYubo International Biotech Ltd.76.29% -$0.00 -$1.5M HOLXHologic, Inc.55.75% $0.79 $7.8B -
What do Analysts Say About YBGJ or HOLX?
Yubo International Biotech Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Hologic, Inc. has an analysts' consensus of $76.60 which suggests that it could grow by 1.65%. Given that Hologic, Inc. has higher upside potential than Yubo International Biotech Ltd., analysts believe Hologic, Inc. is more attractive than Yubo International Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings YBGJYubo International Biotech Ltd.0 0 0 HOLXHologic, Inc.0 16 0 -
Is YBGJ or HOLX More Risky?
Yubo International Biotech Ltd. has a beta of 0.799, which suggesting that the stock is 20.114% less volatile than S&P 500. In comparison Hologic, Inc. has a beta of 0.729, suggesting its less volatile than the S&P 500 by 27.146%.
-
Which is a Better Dividend Stock YBGJ or HOLX?
Yubo International Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Yubo International Biotech Ltd. pays -- of its earnings as a dividend. Hologic, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios YBGJ or HOLX?
Yubo International Biotech Ltd. quarterly revenues are --, which are smaller than Hologic, Inc. quarterly revenues of $1B. Yubo International Biotech Ltd.'s net income of -$310.2K is lower than Hologic, Inc.'s net income of $179.1M. Notably, Yubo International Biotech Ltd.'s price-to-earnings ratio is -- while Hologic, Inc.'s PE ratio is 31.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Yubo International Biotech Ltd. is 12.99x versus 4.12x for Hologic, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income YBGJYubo International Biotech Ltd.12.99x -- -- -$310.2K HOLXHologic, Inc.4.12x 31.27x $1B $179.1M
-
Which has Higher Returns YBGJ or LNMG?
Linike Medical Group Ltd. has a net margin of -11740.4% compared to Yubo International Biotech Ltd.'s net margin of --. Yubo International Biotech Ltd.'s return on equity of -- beat Linike Medical Group Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital YBGJYubo International Biotech Ltd.76.29% -$0.00 -$1.5M LNMGLinike Medical Group Ltd.-- -- -- -
What do Analysts Say About YBGJ or LNMG?
Yubo International Biotech Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Linike Medical Group Ltd. has an analysts' consensus of -- which suggests that it could grow by 98674.37%. Given that Linike Medical Group Ltd. has higher upside potential than Yubo International Biotech Ltd., analysts believe Linike Medical Group Ltd. is more attractive than Yubo International Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings YBGJYubo International Biotech Ltd.0 0 0 LNMGLinike Medical Group Ltd.0 0 0 -
Is YBGJ or LNMG More Risky?
Yubo International Biotech Ltd. has a beta of 0.799, which suggesting that the stock is 20.114% less volatile than S&P 500. In comparison Linike Medical Group Ltd. has a beta of -6.348, suggesting its less volatile than the S&P 500 by 734.788%.
-
Which is a Better Dividend Stock YBGJ or LNMG?
Yubo International Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Linike Medical Group Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Yubo International Biotech Ltd. pays -- of its earnings as a dividend. Linike Medical Group Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios YBGJ or LNMG?
Yubo International Biotech Ltd. quarterly revenues are --, which are larger than Linike Medical Group Ltd. quarterly revenues of --. Yubo International Biotech Ltd.'s net income of -$310.2K is higher than Linike Medical Group Ltd.'s net income of --. Notably, Yubo International Biotech Ltd.'s price-to-earnings ratio is -- while Linike Medical Group Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Yubo International Biotech Ltd. is 12.99x versus 1.95x for Linike Medical Group Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income YBGJYubo International Biotech Ltd.12.99x -- -- -$310.2K LNMGLinike Medical Group Ltd.1.95x -- -- --
-
Which has Higher Returns YBGJ or NUWE?
Nuwellis, Inc. has a net margin of -11740.4% compared to Yubo International Biotech Ltd.'s net margin of 21.11%. Yubo International Biotech Ltd.'s return on equity of -- beat Nuwellis, Inc.'s return on equity of -1004.06%.
Company Gross Margin Earnings Per Share Invested Capital YBGJYubo International Biotech Ltd.76.29% -$0.00 -$1.5M NUWENuwellis, Inc.65.18% $0.56 $4.3M -
What do Analysts Say About YBGJ or NUWE?
Yubo International Biotech Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nuwellis, Inc. has an analysts' consensus of $13.00 which suggests that it could grow by 30496.06%. Given that Nuwellis, Inc. has higher upside potential than Yubo International Biotech Ltd., analysts believe Nuwellis, Inc. is more attractive than Yubo International Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings YBGJYubo International Biotech Ltd.0 0 0 NUWENuwellis, Inc.0 1 0 -
Is YBGJ or NUWE More Risky?
Yubo International Biotech Ltd. has a beta of 0.799, which suggesting that the stock is 20.114% less volatile than S&P 500. In comparison Nuwellis, Inc. has a beta of -0.033, suggesting its less volatile than the S&P 500 by 103.263%.
-
Which is a Better Dividend Stock YBGJ or NUWE?
Yubo International Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Yubo International Biotech Ltd. pays -- of its earnings as a dividend. Nuwellis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios YBGJ or NUWE?
Yubo International Biotech Ltd. quarterly revenues are --, which are smaller than Nuwellis, Inc. quarterly revenues of $2.2M. Yubo International Biotech Ltd.'s net income of -$310.2K is lower than Nuwellis, Inc.'s net income of $468K. Notably, Yubo International Biotech Ltd.'s price-to-earnings ratio is -- while Nuwellis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Yubo International Biotech Ltd. is 12.99x versus 0.41x for Nuwellis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income YBGJYubo International Biotech Ltd.12.99x -- -- -$310.2K NUWENuwellis, Inc.0.41x -- $2.2M $468K
-
Which has Higher Returns YBGJ or QTRX?
Quanterix Corp. has a net margin of -11740.4% compared to Yubo International Biotech Ltd.'s net margin of -83.31%. Yubo International Biotech Ltd.'s return on equity of -- beat Quanterix Corp.'s return on equity of -30.04%.
Company Gross Margin Earnings Per Share Invested Capital YBGJYubo International Biotech Ltd.76.29% -$0.00 -$1.5M QTRXQuanterix Corp.42.77% -$0.73 $354.7M -
What do Analysts Say About YBGJ or QTRX?
Yubo International Biotech Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Quanterix Corp. has an analysts' consensus of $7.33 which suggests that it could grow by 11.96%. Given that Quanterix Corp. has higher upside potential than Yubo International Biotech Ltd., analysts believe Quanterix Corp. is more attractive than Yubo International Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings YBGJYubo International Biotech Ltd.0 0 0 QTRXQuanterix Corp.0 3 0 -
Is YBGJ or QTRX More Risky?
Yubo International Biotech Ltd. has a beta of 0.799, which suggesting that the stock is 20.114% less volatile than S&P 500. In comparison Quanterix Corp. has a beta of 1.056, suggesting its more volatile than the S&P 500 by 5.57%.
-
Which is a Better Dividend Stock YBGJ or QTRX?
Yubo International Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Yubo International Biotech Ltd. pays -- of its earnings as a dividend. Quanterix Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios YBGJ or QTRX?
Yubo International Biotech Ltd. quarterly revenues are --, which are smaller than Quanterix Corp. quarterly revenues of $40.2M. Yubo International Biotech Ltd.'s net income of -$310.2K is higher than Quanterix Corp.'s net income of -$33.5M. Notably, Yubo International Biotech Ltd.'s price-to-earnings ratio is -- while Quanterix Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Yubo International Biotech Ltd. is 12.99x versus 2.04x for Quanterix Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income YBGJYubo International Biotech Ltd.12.99x -- -- -$310.2K QTRXQuanterix Corp.2.04x -- $40.2M -$33.5M
-
Which has Higher Returns YBGJ or VREX?
Varex Imaging Corp. has a net margin of -11740.4% compared to Yubo International Biotech Ltd.'s net margin of 1.15%. Yubo International Biotech Ltd.'s return on equity of -- beat Varex Imaging Corp.'s return on equity of -13.14%.
Company Gross Margin Earnings Per Share Invested Capital YBGJYubo International Biotech Ltd.76.29% -$0.00 -$1.5M VREXVarex Imaging Corp.33.3% $0.05 $892.1M -
What do Analysts Say About YBGJ or VREX?
Yubo International Biotech Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Varex Imaging Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 36.67%. Given that Varex Imaging Corp. has higher upside potential than Yubo International Biotech Ltd., analysts believe Varex Imaging Corp. is more attractive than Yubo International Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings YBGJYubo International Biotech Ltd.0 0 0 VREXVarex Imaging Corp.3 1 0 -
Is YBGJ or VREX More Risky?
Yubo International Biotech Ltd. has a beta of 0.799, which suggesting that the stock is 20.114% less volatile than S&P 500. In comparison Varex Imaging Corp. has a beta of 0.884, suggesting its less volatile than the S&P 500 by 11.581%.
-
Which is a Better Dividend Stock YBGJ or VREX?
Yubo International Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Yubo International Biotech Ltd. pays -- of its earnings as a dividend. Varex Imaging Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios YBGJ or VREX?
Yubo International Biotech Ltd. quarterly revenues are --, which are smaller than Varex Imaging Corp. quarterly revenues of $209.6M. Yubo International Biotech Ltd.'s net income of -$310.2K is lower than Varex Imaging Corp.'s net income of $2.4M. Notably, Yubo International Biotech Ltd.'s price-to-earnings ratio is -- while Varex Imaging Corp.'s PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Yubo International Biotech Ltd. is 12.99x versus 0.68x for Varex Imaging Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income YBGJYubo International Biotech Ltd.12.99x -- -- -$310.2K VREXVarex Imaging Corp.0.68x 17.58x $209.6M $2.4M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Mar 2
Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.
Buy
90
BNAI alert for Mar 2
Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.
Sell
36
WLDN alert for Mar 2
Willdan Group, Inc. [WLDN] is down 1.93% over the past day.
